RxDoctor Payments Data

Matthew McDonnell, MD

Orthopaedic Surgery · Somerset, NJNPI 1770785883

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $48,540 of the $62,007 with a category attached, or 78.3%. 17 manufacturers reported payments, led by Collagen Matrix, Inc at 39.8% of the total. Among orthopaedic surgery clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$62,007in general payments, 2019–2025

Across 137 payments — averaging $452.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collagen Matrix, Inc$25K
  • Stryker$9K
  • Johnson & Johnson$8K
  • Alphatec Spine, Inc$8K
  • Globus Medical$6K
  • Medical Device Business Services, Inc.$4K
  • plus $1K from 11 others
$162,511in ownership & investment interests, 2019–2025

Across 4 payments — averaging $40,628 each. An ownership or investment interest held by the physician or an immediate family member.

  • Durastat LLC$163K

What the payments were for

  • Consulting fees$48,54078%
  • Travel & lodging$8,50414%
  • Food & beverage$4,9278%
  • Entertainment$360%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$62,007 in reported general payments places this provider in the 90th percentile of 587 orthopaedic surgery providers in New Jersey.

See all orthopaedic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$277,106
Medicare patients
363
Services billed
1,547

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cyclobenzaprine Hcl76$523
Methylprednisolone44$288
Cephalexin17$250
Gabapentin47$226
Meloxicam64$195

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Somerset

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →